Syndax Pharmaceuticals, Inc. (SNDX) Operating margin 2016–2025
Syndax Pharmaceuticals, Inc. (SNDX) operating margin by fiscal year — reported operating income divided by reported revenue.
-158.4%FY2025 · since FY2016: -3587.4% → -158.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -158.4% | +1276.0 pp |
| FY2024 | -1434.4% | — |
| FY2021 | 18.8% | +4726.9 pp |
| FY2020 | -4708.2% | -915.2 pp |
| FY2019 | -3792.9% | +1208.8 pp |
| FY2018 | -5001.7% | -2062.7 pp |
| FY2017 | -2939.0% | +648.4 pp |
| FY2016 | -3587.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice